A phase 2 autologous cellular therapy trial in patients with acute, complete spinal cord injury: pragmatics, recruitment, and demographics (Q34109812)

31 July 2017

title

A phase 2 autologous cellular therapy trial in patients with acute, complete spinal cord injury: pragmatics, recruitment, and demographics (English)

1 reference

31 July 2017

main subject

phase II clinical trial

0 references

0 references

2

D P Lammertse

1 reference

31 July 2017

L A T Jones

1

1 reference

31 July 2017

S B Charlifue

3

1 reference

31 July 2017

S C Kirshblum

4

1 reference

31 July 2017

D F Apple

5

1 reference

31 July 2017

K T Ragnarsson

6

1 reference

31 July 2017

D Poonian

7

1 reference

31 July 2017

R R Betz

8

1 reference

31 July 2017

N Knoller

9

1 reference

31 July 2017

R F Heary

10

1 reference

31 July 2017

T F Choudhri

11

1 reference

31 July 2017

A L Jenkins

12

1 reference

31 July 2017

S P Falci

13

1 reference

31 July 2017

D A Snyder

14

1 reference

31 July 2017

publication date

13 April 2010

1 reference

31 July 2017

1 reference

31 July 2017

volume

48

1 reference

31 July 2017

issue

11

1 reference

31 July 2017

page(s)

798-807

1 reference

A Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord Injury

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSC.2010.29

Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSC.2010.29

A test of the 1992 International Standards for Neurological and Functional Classification of Spinal Cord Injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSC.2010.29

Patient selection for clinical trials: the reliability of the early spinal cord injury examination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSC.2010.29

A demographic profile of new traumatic spinal cord injuries: change and stability over 30 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSC.2010.29

The Sygen multicenter acute spinal cord injury study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSC.2010.29

7 January 2021

Efficacy of Methylprednisolone in Acute Spinal Cord Injury

1 reference

https://api.crossref.org/works/10.1038%2FSC.2010.29

7 January 2021

Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord I

1 reference

https://api.crossref.org/works/10.1038%2FSC.2010.29

7 January 2021

Clinical experience using incubated autologous macrophages as a treatment for complete spinal cord injury: phase I study results

1 reference

https://api.crossref.org/works/10.1038%2FSC.2010.29

7 January 2021

The interobserver reliability of the revised American Spinal Injury Association standards for neurological classification of spinal injury patients.

1 reference

https://api.crossref.org/works/10.1038%2FSC.2010.29

7 January 2021

Reliability and repeatability of the motor and sensory examination of the international standards for neurological classification of spinal cord injury

1 reference

https://api.crossref.org/works/10.1038%2FSC.2010.29

7 January 2021

Identifiers

DOI

10.1038/SC.2010.29

1 reference

Dimensions Publication ID

31 July 2017

1051607550

0 references

1 reference